Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14668 | 688 | 35.7 | 55% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
44 | 31062 | SCHIZOPHRENIA//SCHIZOPHRENIA RESEARCH//SCHIZOPHRENIA BULLETIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLINICAL GLOBAL IMPRESSIONS SCALE | Author keyword | 6 | 71% | 1% | 5 |
2 | FUNCTIONAL REMISSION | Author keyword | 5 | 60% | 1% | 6 |
3 | SYMPTOMATIC REMISSION | Author keyword | 4 | 47% | 1% | 7 |
4 | EQUIPERCENTILE LINKING | Author keyword | 4 | 67% | 1% | 4 |
5 | NETWORKED BIOMED MENTAL HLTH CIBERSAM | Address | 4 | 75% | 0% | 3 |
6 | ST ANNE HOSP CMME | Address | 3 | 50% | 1% | 4 |
7 | GEOPTE SCALE | Author keyword | 2 | 67% | 0% | 2 |
8 | KARL JASPERS KLIN | Address | 2 | 67% | 0% | 2 |
9 | TREATMENT TRAJECTORIES | Author keyword | 2 | 67% | 0% | 2 |
10 | UNMEDICATED PATIENTS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYMPTOMATIC REMISSION | 33 | 75% | 3% | 24 |
2 | ONSET HYPOTHESIS | 25 | 51% | 5% | 35 |
3 | ANTIPSYCHOTIC DRUG TRIALS | 15 | 88% | 1% | 7 |
4 | CGI | 11 | 65% | 2% | 11 |
5 | FUNCTIONAL REMISSION | 9 | 67% | 1% | 8 |
6 | ANTIPSYCHOTIC TREATMENT RESPONSE | 4 | 67% | 1% | 4 |
7 | PANSS | 4 | 12% | 4% | 29 |
8 | CGI S | 3 | 100% | 0% | 3 |
9 | AMISULPRIDE VS RISPERIDONE | 3 | 29% | 1% | 8 |
10 | ANTIPSYCHOTIC RESPONSE | 3 | 35% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Psychopathological long-term outcome of schizophrenia - a review | 2013 | 17 | 42 | 43% |
Clinical relevance of findings in trials of antipsychotics: systematic review | 2011 | 30 | 14 | 50% |
Setting new standards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria | 2012 | 8 | 20 | 75% |
Remission in Schizophrenia: Critical and Systematic Review | 2012 | 10 | 59 | 59% |
A SELECTIVE REVIEW OF RECENT NORTH-AMERICAN LONG-TERM FOLLOW-UP STUDIES OF SCHIZOPHRENIA | 1988 | 377 | 29 | 45% |
THE NATURAL COURSE OF SCHIZOPHRENIA - A REVIEW OF 1ST-ADMISSION STUDIES | 1992 | 122 | 35 | 40% |
Comparative remission rates of schizophrenic patients using various remission criteria | 2008 | 15 | 24 | 54% |
Remission in schizophrenia: Proposed criteria and rationale for consensus | 2005 | 694 | 40 | 13% |
Response and remission in schizophrenic subjects | 2011 | 3 | 17 | 65% |
The varied outcomes of schizophrenia | 1997 | 126 | 100 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NETWORKED BIOMED MENTAL HLTH CIBERSAM | 4 | 75% | 0.4% | 3 |
2 | ST ANNE HOSP CMME | 3 | 50% | 0.6% | 4 |
3 | KARL JASPERS KLIN | 2 | 67% | 0.3% | 2 |
4 | EV KRANKENHAUS BETHANIEN | 1 | 100% | 0.3% | 2 |
5 | ST ANNE HOSP SHU | 1 | 100% | 0.3% | 2 |
6 | PEDIC | 1 | 17% | 0.7% | 5 |
7 | AUTONOMES NEUROENDOKRINOL FUNKT OR | 1 | 50% | 0.1% | 1 |
8 | CNRS HP | 1 | 50% | 0.1% | 1 |
9 | CNRSCREA | 1 | 50% | 0.1% | 1 |
10 | EENHEID BIOSTAT MED INFORMAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000254358 | DURATION OF UNTREATED PSYCHOSIS//PRODROME//EARLY INTERVENTION IN PSYCHIATRY |
2 | 0.0000217173 | NEGATIVE SYMPTOMS//DEFICIT SYNDROME//PANSS |
3 | 0.0000213257 | LATE PARAPHRENIA//LATE ONSET SCHIZOPHRENIA//PARAPHRENIA |
4 | 0.0000189033 | PALIPERIDONE PALMITATE//LONG ACTING RISPERIDONE//OLANZAPINE PAMOATE |
5 | 0.0000187802 | SECTOR NE//LANCASHIRE QUALITY OF LIFE PROFILE//QLDS |
6 | 0.0000185449 | ACUTE AND TRANSIENT PSYCHOTIC DISORDERS//CYCLOID PSYCHOSIS//REACTIVE PSYCHOSIS |
7 | 0.0000153110 | PSYCHIATRIC REHABILITATION JOURNAL//CONSUMER OPERATED SERVICES//ILLNESS MANAGEMENT AND RECOVERY |
8 | 0.0000150535 | COCHRANE IZOPHRENIA GRP//WARM SUPPLEMENTING KIDNEY YANG//SURG DEV SCI |
9 | 0.0000148544 | BORRTI//EGO FUNCTIONING//COMPARISONS OF PSYCHOTHERAPIES |
10 | 0.0000147989 | CLOZAPINE//RISPERIDONE//OLANZAPINE |